We found that the percentage of cells expressing Ki-67 in the ultrasonic samples from the tumor core was within 7.9 ± 4.0% (n = 6 gliomas) of the Ki-67 expression in the tumor biopsy (Figure 2B and C). The gene discussed is MKI67; the disease is central nervous system cancer.